CHIEN TSAI: Open Payments
NPI 1700898640 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 86 payments from 8 companies in 2025. Trend: 2023 $939 · 2024 $1,440 · 2025 $1,453
Food & beverage: $1,453
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $400 |
| Teva Pharmaceuticals USA, Inc. | 16 | $245 |
| ABBVIE INC. | 21 | $228 |
| Alkermes, Inc. | 11 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $147 |
| Neurocrine BioSciences, Inc. | 5 | $121 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| Lundbeck LLC | 3 | $65 |
Products named: REXULTI, VRAYLAR, ABILIFY MAINTENA, ARISTADA, UZEDY, CAPLYTA, INGREZZA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
